Featured Article
Stem Cell Trial For AMD Approved
A clinical trial of a human embryonic stem cell (ESC) therapy for age-related macular degeneration has been approved by the FDA, making it the first such study for a common disease.
Resequencing Chip Enables Rapid Detection Of Mutations In Retinal Disease Genes
A custom resequencing chip accurately and efficiently identified novel and known mutations in retinal disease genes in multiple patients, a study conducted in the Netherlands found.
A cost-effectiveness analysis of three treatments for age-related macular degeneration
This study evaluated the cost-effectiveness of pegaptanib sodium or ranibizumab injections, compared with photodynamic therapy (PDT) with verteporfin for treating choroidal neovascularisation in patients with age-related macular degeneration. The autho…
Applied In Vivo Clinical Histology II: A New Way to Look at Retinal Disease
Stem Cell Trial for AMD Approved
(MedPage Today) — A clinical trial of a human embryonic stem cell (ESC) therapy for age-related macular degeneration has been approved by the FDA, making it the first such study for a common disease.